机译:ObInutuzumab vs Rituximab用于高级DLBCL:Lysa的宠物引导和随机阶段3研究
Clin Ctr Hosp Univ CHU Nantes Serv Hematol Nantes France;
Univ Claude Bernard Lyon 1 Hosp Civils Lyon Ctr Hosp Lyon Sud Dept Hematol Lyon France;
Inst Univ Canc IUC Toulouse Oncopole Serv Hematol Toulouse France;
Univ Lille Dept Hematol CHU Lille Lille France;
Ctr Henri Becquerel Dept Hematol Rouen France;
Univ Paris Saclay Dept Hematol Gustave Roussy Villejuif France;
Univ Hosp Rennes Dept Hematol Rennes France;
Univ Paris Diderot Hop St Louis Assistance Publ Hop Paris AP HP Dept Hematol Paris France;
Hop Dept Vendee Dept Hematol La Roche Sur Yon France;
CHU Grenoble Dept Hematol Grenoble France;
Univ Hosp Bordeaux Dept Hematol Bordeaux France;
Hop H Mondor Dept Hematol Creteil France;
Inst Hematol Basse Normandie Dept Hematol Caen France;
Univ Hosp Strasbourg Dept Hematol Strasbourg France;
Inst P Calmette Dept Hematol Marseille France;
Univ Hosp Nancy Dept Hematol Vandoeuvre Les Nancy France;
Hop Necker Enfants Malad Dept Hematol Paris France;
Univ Hosp Montpellier Dept Hematol Montpellier France;
CHU Liege Dept Hematol Liege Belgium;
CHU Univ Catholique Louvain UCL Namur Dept Hematol Yvoir Belgium;
Lymphoma Acad Res Org LYSARC Dept Biostat Lyon France;
Ctr Henri Becquerel INSERM U1245 Rouen France;
Univ Hosp Nantes Dept Nucl Med Nantes France;
Univ Hosp Nantes Dept Nucl Med Nantes France;
Ctr Georges Francois Leclerc Dept Nucl Med Dijon France;
Univ Paris Diderot Hop St Louis Assistance Publ Hop Paris AP HP Dept Hematol Paris France;
Univ Paris Dept Biostat Hop Necker Paris France;
Unite INSERM 1163 Inst Imagine Paris France;
Hop H Mondor Dept Nucl Med Creteil France;
Univ Hosp F Mitterrand Dept Hematol Dijon France;
机译:Polatuzumab Vedotin(pola)加上叶蛋白(b)与Rituximab(R)或obInutuzumab(g)复发/难以(r / r)弥漫性大b细胞淋巴瘤(dlbcl):相位(pH)Ib / II的更新结果 学习
机译:obInutuzumab的II期Lysa研究联合Lenalidomide用于全身治疗的先进未封闭卵泡B细胞淋巴瘤
机译:来自Lysa的Remarc研究对国际上进行的双盲随机三期研究的一线研究,该研究对R-CHOP治疗老年DLBCL的来那度胺的老年患者进行了研究
机译:全面研究高级SiGe HBT的基极和收集器中的随机电报噪声:偏置,几何形状和陷阱位置
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:奥比妥珠单抗或利妥昔单抗联合CHOP治疗先前未经治疗的弥漫性大B细胞淋巴瘤患者的一项随机开放标签III期研究:GOYA的最终分析
机译:在先前未经处理的弥漫性大B细胞淋巴瘤的患者中,ObInutuzumab或Rituximab加入的随机开放标签,阶段III研究:GOYA的最终分析
机译:提升转子随机载荷和振动的理论和实验研究概念。 6-a叶片扭转,叶片弯曲弯曲灵活性和转子支撑灵活性对转子稳定性和随机响应的影响